1983
DOI: 10.1016/0378-4274(83)90128-5
|View full text |Cite
|
Sign up to set email alerts
|

Early effects of high-dosed absorbable amoscanate on rat brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1988
1988
2010
2010

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 3 publications
0
9
0
Order By: Relevance
“…1, 2011 TOXICOLOGY OF VENTRICULAR CSF-BORDERING CELLScurative oral dose is typically 10 to 60 mg/kg (Bueding, Batzinger, and Petterson 1976). Adsorbable amoscanate given to an adult induced a lesion in the ependyma but not in CP by three days after administration of consecutive high oral doses (125 or 500 mg/kg) (Clark, Kiel, and Parhad 1982;Krinke et al 1983). Amoscanate caused necrosis by 28 days to the lateral walls of both telencephalic ventricles; interestingly, the lesion ( Figure 11) was confined to the caudate/putamen surface and generally spared the brain, spinal cord, and peripheral nerves.…”
Section: Injuries To Ependymamentioning
confidence: 99%
See 1 more Smart Citation
“…1, 2011 TOXICOLOGY OF VENTRICULAR CSF-BORDERING CELLScurative oral dose is typically 10 to 60 mg/kg (Bueding, Batzinger, and Petterson 1976). Adsorbable amoscanate given to an adult induced a lesion in the ependyma but not in CP by three days after administration of consecutive high oral doses (125 or 500 mg/kg) (Clark, Kiel, and Parhad 1982;Krinke et al 1983). Amoscanate caused necrosis by 28 days to the lateral walls of both telencephalic ventricles; interestingly, the lesion ( Figure 11) was confined to the caudate/putamen surface and generally spared the brain, spinal cord, and peripheral nerves.…”
Section: Injuries To Ependymamentioning
confidence: 99%
“…Magnification is 5053Â. From Krinke et al (1983). Due to unavoidable circumstances the above figures were not originals but were scanned from reprints.…”
Section: Injuries To Circumventricular Organsmentioning
confidence: 99%
“…The clinical signs were essentially non-specific (reduced exploratory activity, reduced body tone, piloerection, braydypnea, reduced body weight gain) except for an ataxic gait and an increased fearfulness which were attributed to the specific central-nervous action of the substance (Krinke et al 1983). The intensity of the signs increased both time-dependent and dose-dependent.…”
Section: Clinical Signsmentioning
confidence: 94%
“…Amoscanate is available in two forms: the first, poorly absorbed from the gastrointestinal tract, is used against hookworm infection (Doshi et al 1977); the second, which is well absorbed, is highly effective against schistosomiasis even when administered as a single oral dose (Striebel 1976). Neuropathologic lesions in the rat brain have only been observed when the absorbable form was repeatedly administered at high dosages ; at least three consecutive daily (oral) doses of 125 mg/ kg or 500 mg/ kg were required to damage the ependymal cell lining, and periventricular necrosis occurred following a 1 0-day treatment (Krinke et al 1983). …”
Section: Biologic Featuresmentioning
confidence: 96%
“…92,93). Occasional reactive astrocytes are formed at the border of the damaged area (Krinke et al 1983). The microgranules, in the areas of periventricular necrosis, are characterized by an amorphous, electron-dense structure occasionally showing a pattern of concentric lines; some of them may contain lamellar structures resembling mitochondria (Clark et al 1982).…”
Section: Ultrastructurementioning
confidence: 98%